Dechra Veterinary Products Inc. has voluntarily recalled 3,648 bottles of Felimazole (methimazole) Coated Tablets (5mg) used for treating hyperthyroidism in cats. This recall was initiated after a batch of the tablets was found to be subpotent during a 3-month quality test. The affected product was distributed to three customers in Missouri and one customer in Pennsylvania in bottles containing 100 tablets each.
Because these tablets are subpotent, they do not contain the full required amount of the active medication, methimazole. This could result in ineffective treatment of a cat's hyperthyroidism, leading to poorly managed symptoms of the condition.
Drug Recall Refund/Guidance
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response